Thousands of potentially disease-ridden monkeys crisscross the U.S., often without legally required inspections, according to primate researcher Lisa Jones-Engel, Ph.D. The monkeys are destined for labs where they’re used for medical research that most often produces little in the way of meaningful results.
The transportation of potentially disease-ridden monkeys used for medical research is a $1.25 billion international business.
In the U.S., much of that research — largely funded by U.S. taxpayers — is “irrelevant,” “misleading” and poses a serious public health threat, according to a senior research scientist at the Washington National Primate Research Center.
In an article she authored for the Independent Media Institute, Lisa Jones-Engel, Ph.D., who has studied primates for nearly 40 years, wrote:
“Despite decades of promises and hundreds of thousands of dead monkeys, experiments using monkeys have not resulted in effective vaccines for HIV, tuberculosis, malaria or other dreaded human diseases.
“COVID-19 experiments have shown the scientific community how irrelevant and often misleading monkey studies are.”
